Literature DB >> 33848996

Automatic classification of idiopathic Parkinson's disease and atypical parkinsonian syndromes combining [11C]raclopride PET uptake and MRI grey matter morphometry.

Ricardo Martins1, Francisco Paulo Marques Oliveira2, Fradique Moreira3, Ana Paula Moreira4, Antero Abrunhosa4, Cristina Januario4, Miguel Castelo-Branco4.   

Abstract

OBJECTIVE: To explore the viability of developing a computer-aided diagnostic system for Parkinsonian syndromes using dynamic [11C]raclopride PET and T1-weighted MRI data. APPROACH: The biological heterogeneity of Parkinsonian syndromes renders their statistical classification a challenge. The unique combination of structural and molecular imaging data allowed different classifier designs to be tested. Datasets from dynamic [11C]raclopride PET and T1-weighted MRI scans were acquired from six groups of participants: healthy controls (CTRL n=15), patients with Parkinson's disease (PD n=27), multiple system atrophy (MSA n=8), corticobasal degeneration (CBD n=6), and dementia with Lewy bodies (DLB n=5). MSA, CBD, and DLB patients were classified into one category designated as atypical parkinsonism (AP). The distribution volume ratio (DVR) kinetic parameters obtained from PET data were used to quantify the reversible tracer binding to D2/D3 receptors in the subcortical regions of interest (ROI). Grey matter (GM) volumes obtained from the MRI data were used to quantify GM atrophy across cortical, subcortical, and cerebellar ROI.
RESULTS: The classifiers CTRL vs PD and CTRL vs AP achieved the highest balanced accuracy combining DVR and GM (DVR-GM) features (96.7%, 92.1%, respectively), followed by the classifiers designed with DVR features (93.3%, 88.8%, respectively), and GM features (69.6%, 86.1%, respectively). In contrast, the classifier PD vs AP showed the highest balanced accuracy (78.9%) using DVR features only. The integration of DVR-GM (77.9%) and GM features (72.7%) produced inferior performances. The classifier CTRL vs PD vs AP showed high weighted balanced accuracy when DVR (80.5%) or DVR-GM features (79.9%) were integrated. GM features revealed poorer performance (59.5%). SIGNIFICANCE: This work was unique in its combination of structural and molecular imaging features in binary and triple category classifications. We were able to demonstrate improved binary classification of healthy/diseased status (concerning both PD and AP) and equate performance to DVR features in multiclass classifications. Creative Commons Attribution license.

Entities:  

Keywords:  11C-Raclopride positron emission tomography; Computer-aided diagnosis; Parkinsonian syndromes; machine learning; magnetic resonance imaging; multimodality imaging

Year:  2021        PMID: 33848996     DOI: 10.1088/1741-2552/abf772

Source DB:  PubMed          Journal:  J Neural Eng        ISSN: 1741-2552            Impact factor:   5.379


  3 in total

1.  Effects of Pramipexole Combined with Nerve Growth Factor on Cognitive Impairment and Urinary AD7c-NTP Expression in Patients with Parkinson's Disease.

Authors:  Zhengxin Wang; Saiyu Cheng
Journal:  Comput Math Methods Med       Date:  2022-04-26       Impact factor: 2.809

2.  Dual PET-fMRI reveals a link between neuroinflammation, amyloid binding and compensatory task-related brain activity in Alzheimer's disease.

Authors:  Nádia Canário; Lília Jorge; Ricardo Martins; Isabel Santana; Miguel Castelo-Branco
Journal:  Commun Biol       Date:  2022-08-10

Review 3.  Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.

Authors:  Seung Hyun Lee; Sang-Min Park; Sang Seok Yeo; Ojin Kwon; Mi-Kyung Lee; Horyong Yoo; Eun Kyoung Ahn; Jae Young Jang; Jung-Hee Jang
Journal:  Diagnostics (Basel)       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.